A Study for Patients With Multiple Sclerosis

Summary

To obtain additional safety data in subjects who have previously completed the MBP8298-01 study "A Double Blind Placebo Controlled Multi-Centre to Evaluate the Efficacy and Safety of MBP8298 in Subjects with Secondary Multiple Sclerosis" Dirucotide is generic name for MBP8298.

Timeline

Start

2007-02

Primary completion

2009-09

Completion

2009-09

Outcome

Outcome not reported

Stopped: “Negative efficacy results of the MAESTRO-01 trial”

Drugs

Indications